Cemiplimab/Fianlimab

cemiplimab and fianlimab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cemiplimab/Fianlimab, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

See pricing